Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease
- PMID: 16950016
- DOI: 10.1016/j.vaccine.2006.06.015
Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease
Abstract
Human Papillomavirus (HPV)-6 and -11 are the causative agents of ano-genital warts (GWs) and recurrent respiratory papillomatosis (RRP). They are low-risk HPV types that are uncommonly found in malignant lesions. GWs are an extremely prevalent sexually transmitted disease, whereas RRP is a rare disease that can be life threatening and requires multiple surgical procedures. GWs and RRP cause substantial healthcare costs. A quadrivalent HPV-6/11/16/18 vaccine (Merck/SPMSD) has shown essentially 100% protection against GWs in women in early studies. Cost-effectiveness analyses are needed to assess the benefits of the HPV-6/11 virus-like particle (VLP) components of the quadrivalent vaccine in population-based vaccination programmes.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical